RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS

      소아 기능성 요실금의 진단과 치료 = Diagnosis and therapy for functional urinary incontinence in childhood

      한글로보기

      https://www.riss.kr/link?id=A104549787

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Functional urinary incontinence, the absence of any neurologic or structural abnormality as a cause of urinary incontinence in children, is one of the most common clinical problems encountered in pediatric and urologic departments, and it can be socially and emotionally distressing for the affected children. The prevalence rates of functional urinary incontinence in school-aged children are not very high and differ between boys and girls. The underlying mechanisms of functional urinary incontinence are heterogenous and can be associated with the following dysfunctions of both the storage and voiding patterns of the bladder: overactive bladder, dysfunctional voiding, lazy bladder syndrome, HinmanAllen syndrome, giggle incontinence, and vaginal voiding. Treatment methods for urinary incontinence in children should be chosen according to these clinical conditions. Treatment modalities generally consist of the treatment of comorbid conditions such as urinary infection and constipation, behavior therapy to modify learned voiding patterns, and pharmacotherapy primarily with anticholinergics and α-adrenergic blockers. This review discusses the optimal treatment modalities, including treatment of the underlying voiding disorders, and diagnostic approaches related to functional urinary incontinence in children.
      번역하기

      Functional urinary incontinence, the absence of any neurologic or structural abnormality as a cause of urinary incontinence in children, is one of the most common clinical problems encountered in pediatric and urologic departments, and it can be socia...

      Functional urinary incontinence, the absence of any neurologic or structural abnormality as a cause of urinary incontinence in children, is one of the most common clinical problems encountered in pediatric and urologic departments, and it can be socially and emotionally distressing for the affected children. The prevalence rates of functional urinary incontinence in school-aged children are not very high and differ between boys and girls. The underlying mechanisms of functional urinary incontinence are heterogenous and can be associated with the following dysfunctions of both the storage and voiding patterns of the bladder: overactive bladder, dysfunctional voiding, lazy bladder syndrome, HinmanAllen syndrome, giggle incontinence, and vaginal voiding. Treatment methods for urinary incontinence in children should be chosen according to these clinical conditions. Treatment modalities generally consist of the treatment of comorbid conditions such as urinary infection and constipation, behavior therapy to modify learned voiding patterns, and pharmacotherapy primarily with anticholinergics and α-adrenergic blockers. This review discusses the optimal treatment modalities, including treatment of the underlying voiding disorders, and diagnostic approaches related to functional urinary incontinence in children.

      더보기

      참고문헌 (Reference)

      1 Austin PF, "a-Adrenergic blockade in children with neuropathic and nonneuropathic voiding dysfunction" 162 : 1064-1067, 1999

      2 Loening-Baucke V, "Urinary incontinence and urinary tract infection and their resolution with treatment of chronic constipation of childhood" 100 : 228-232, 1997

      3 Sureshkumar P, "Treatment of daytime urinary incontinence in children: a systematic review of randomized controlled trials" 170 : 196-200, 2003

      4 Nijman RJ, "Tolterodine treatment for children with symptoms of urinary urge incontinence suggestive of detrusor overactivity: results from 2 randomized, placebo controlled trials" 173 : 1334-1339, 2005

      5 Deluca FG, "The dysfunctional lazy bladder syndrome in children" 37 : 117-121, 1962

      6 Sher PK, "Successful treatment of giggle incontinence with methylphendiate" 156 : 656-658, 1996

      7 Nørgaard JP, "Standardization and definitions in lower urinary tract dysfunction in children. International Children's Continence Society" 81 (81): s1-s16, 1998

      8 Bauer SB, "Special considerations of the overactive bladder in children" 60 : 43-49, 2002

      9 Raes A, "Retrospective analysis of efficacy and tolerability of tolterodine in children with overactive bladder" 45 : 240-244, 2004

      10 Hellström AL, "Rehabilitation of the dysfunctional bladder in children: method and 3-year followup" 138 : 847-849, 1987

      1 Austin PF, "a-Adrenergic blockade in children with neuropathic and nonneuropathic voiding dysfunction" 162 : 1064-1067, 1999

      2 Loening-Baucke V, "Urinary incontinence and urinary tract infection and their resolution with treatment of chronic constipation of childhood" 100 : 228-232, 1997

      3 Sureshkumar P, "Treatment of daytime urinary incontinence in children: a systematic review of randomized controlled trials" 170 : 196-200, 2003

      4 Nijman RJ, "Tolterodine treatment for children with symptoms of urinary urge incontinence suggestive of detrusor overactivity: results from 2 randomized, placebo controlled trials" 173 : 1334-1339, 2005

      5 Deluca FG, "The dysfunctional lazy bladder syndrome in children" 37 : 117-121, 1962

      6 Sher PK, "Successful treatment of giggle incontinence with methylphendiate" 156 : 656-658, 1996

      7 Nørgaard JP, "Standardization and definitions in lower urinary tract dysfunction in children. International Children's Continence Society" 81 (81): s1-s16, 1998

      8 Bauer SB, "Special considerations of the overactive bladder in children" 60 : 43-49, 2002

      9 Raes A, "Retrospective analysis of efficacy and tolerability of tolterodine in children with overactive bladder" 45 : 240-244, 2004

      10 Hellström AL, "Rehabilitation of the dysfunctional bladder in children: method and 3-year followup" 138 : 847-849, 1987

      11 Smellie JM, "Prophylactic co-trimoxazole and trimethoprim in the management of urinary tract infection in children" 2 : 12-17, 1988

      12 Erickson BA, "Polyethylene glycol 3350 for constipation in children with dysfunctional elimination" 170 : 1518-1520, 2003

      13 Appel RA, "Oxybutynin. The clinical experience" 3 : 60-67, 1991

      14 Wehby MC, "Occult tight filum terminale syndrome: results of surgical untethering" 40 : 51-58, 2004

      15 Saedi NA, "Natural history of voiding dysfunction" 18 : 894-897, 2003

      16 Hellström AL, "Micturition habits and incontinence in 7-year-old Swedish school entrants" 149 : 434-437, 1990

      17 Wiener JS, "Long-term efficacy of simple behavioral therapy for daytime wetting in children" 164 : 786-790, 2000

      18 Wiener JS, "Long-term efficacy of simple behavioral therapy for daytime wetting in children" 164 : 786-790, 2000

      19 Ayan S, "Efficacy of tolterodine as a first-line treatment for non-neurogenic voiding dysfunction in children" 96 : 411-414, 2005

      20 Kim KM, "Efficacy and Tolerability of Tolterodine Compared to Oxybutynin in Children with a Neurogenic Bladder" 46 : 598-603, 2005

      21 Fouron JC, "ECG changes in fatal imipramine (Tofranil) intoxication" 48 : 777-781, 1971

      22 Kramer SA, "Double-blind placebo controlled study of a-adrenergic receptor antagonists (doxazosin) for treatment of voiding dysfunction in the pediatric population" 173 : 2121-2124, 2005

      23 Allen HA, "Cooper CS. Initial trial of timed voiding is warranted for all children with daytime incontinence" 69 : 962-965, 2007

      24 Bauer SB, "Campbell's Urology. 8th Ed" W.B. Saunders Co 2231-2283, 2002

      25 van Gool JD, "Bladder-sphincter dysfunction, urinary infection and vesico-ureteral reflux with special reference to cognitive bladder training" 39 : 190-210, 1984

      26 Goode PS, "Behavioral and drug therapy for urinary incontinence" 63 : s58-s64, 2004

      27 Hoebeke P, "Assessment of lower urinary tract dysfunction in children with nonneuropathic bladder sphincter dysfunction" 35 : 57-69, 1999

      28 Andersson KE, "Antimuscarinics for treatment of overactive bladder" 3 : 46-53, 2004

      29 Cain MP, "Alpha blocker therapy for children with dysfunctional voiding and urinary retention" 170 : 1514-1517, 2003

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-15 학술지명변경 한글명 : Korean Journal of Pediatrics -> Clinical and Experimental Pediatrics
      외국어명 : Korean Journal of Pediatrics -> Clinical and Experimental Pediatrics
      KCI등재
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2019-07-16 학회명변경 한글명 : 대한소아과학회 -> 대한소아청소년과학회 KCI등재
      2010-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-30 학술지명변경 한글명 : 소아과 -> Korean Journal of Pediatrics KCI등재
      2008-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2006-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2003-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2002-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2000-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.18 0.18 0.16
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.17 0.2 0.369 0.06
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼